HNF1A gene polymorphisms and cardiovascular risk factors in individuals with late-onset autosomal dominant diabetes: a cross-sectional study

[1]  S. Dib,et al.  Low prevalence of MODY2 and MODY3 mutations in Brazilian individuals with clinical MODY phenotype. , 2008, Diabetes research and clinical practice.

[2]  M. McCarthy,et al.  Genetic studies of diabetes following the advent of the genome-wide association study: where do we go from here? , 2007, Diabetologia.

[3]  R. Hegele,et al.  Hypertriglyceridemia: its etiology, effects and treatment , 2007, Canadian Medical Association Journal.

[4]  Kristin G Ardlie,et al.  Evaluation of Common Variants in the Six Known Maturity-Onset Diabetes of the Young (MODY) Genes for Association With Type 2 Diabetes , 2007, Diabetes.

[5]  D. Altshuler,et al.  Common variants in HNF-1 α and risk of type 2 diabetes , 2006, Diabetologia.

[6]  F. Collins,et al.  Common Variants in Maturity-Onset Diabetes of the Young Genes Contribute to Risk of Type 2 Diabetes in Finns , 2006, Diabetes.

[7]  M. Kanamori,et al.  Association Studies of Variants in the Genes Involved in Pancreatic β-Cell Function in Type 2 Diabetes in Japanese Subjects , 2006, Diabetes.

[8]  T. Hansen,et al.  A prevalent amino acid polymorphism at codon 98 (Ala98Val) of the hepatocyte nuclear factor-1alpha is associated with maturity-onset diabetes of the young and younger age at onset of type 2 diabetes in Asian Indians. , 2005, Diabetes care.

[9]  Kristin G Ardlie,et al.  Association of common variation in the HNF1alpha gene region with risk of type 2 diabetes. , 2005, Diabetes.

[10]  F. Giuffrida,et al.  Genetic and clinical characteristics of maturity‐onset diabetes of the young , 2005, Diabetes, obesity & metabolism.

[11]  A. Hattersley,et al.  Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels. , 2003, Diabetes.

[12]  A. Gloyn.  Glucokinase (GCK) mutations in hyper‐ and hypoglycemia: Maturity‐onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy , 2003, Human mutation.

[13]  S. Dib,et al.  [Prevalence of immunologic markers (Anti-GAD and Anti-IA2) in first-degree relatives of patients with type I diabetes in the greater area of São Paulo]. , 2003, Revista da Associacao Medica Brasileira.

[14]  L. Chuang,et al.  Comparison of the impact of the I27L polymorphism of the hepatocyte nuclear factor-1alpha on estimated and measured beta cell indices. , 2003, European journal of endocrinology.

[15]  T. Ogihara,et al.  Association of I27L polymorphism of hepatocyte nuclear factor-1 alpha gene with high-density lipoprotein cholesterol level. , 2003, The Journal of clinical endocrinology and metabolism.

[16]  T. Hansen,et al.  A genome-wide scan in families with maturity-onset diabetes of the young: evidence for further genetic heterogeneity. , 2003, Diabetes.

[17]  K. Hanssen,et al.  Heterogeneity of non‐insulin‐dependent diabetes expressed as variability in insulin sensitivity, β‐cell function and cardiovascular risk profile , 2003, Diabetic medicine : a journal of the British Diabetic Association.

[18]  C. Antunes,et al.  Color and genomic ancestry in Brazilians , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  G. Ryffel,et al.  Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: functional and pathological consequences. , 2001, Journal of molecular endocrinology.

[20]  C. Bellanné-Chantelot,et al.  Prevalence of maturity-onset diabetes of the young mutations in Brazilian families with autosomal-dominant early-onset type 2 diabetes. , 2001, Diabetes care.

[21]  L. Niskanen,et al.  Variants in the hepatocyte nuclear factor-1alpha and -4alpha genes in Finnish and Chinese subjects with late-onset type 2 diabetes. , 2000, Diabetes care.

[22]  D. Gaudet,et al.  Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? , 2000, Circulation.

[23]  L. Chuang,et al.  The I27L amino acid polymorphism of hepatic nuclear factor-1alpha is associated with insulin resistance. , 2000, The Journal of clinical endocrinology and metabolism.

[24]  M. McCarthy,et al.  Parent-offspring trios: a resource to facilitate the identification of type 2 diabetes genes. , 1999, Diabetes.

[25]  Allen,et al.  Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes , 1999, The Journal of clinical investigation.

[26]  C. Lindgren,et al.  High frequency of mutations in MODY and mitochondrial genes in Scandinavian patients with familial early-onset diabetes , 1999, Diabetologia.

[27]  A. Krolewski,et al.  Phenotypic characteristics of early-onset autosomal-dominant type 2 diabetes unlinked to known maturity-onset diabetes of the young (MODY) genes. , 1999, Diabetes care.

[28]  J. Levy,et al.  Correct Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program , 1998, Diabetes Care.

[29]  A. M. Møller,et al.  The effect of two frequent amino acid variants of the hepatocyte nuclear factor-1alpha gene on estimates of the pancreatic beta-cell function in Caucasian glucose-tolerant first-degree relatives of type 2 diabetic patients. , 1998, The Journal of clinical endocrinology and metabolism.

[30]  T. Utsugi,et al.  Mutations in the hepatocyte nuclear factor-1α gene (MODY3) are not a major cause of early-onset non-insulin-dependent (type 2) diabetes mellitus in Japanese , 1998, Journal of Human Genetics.

[31]  P. Behn,et al.  Hepatocyte nuclear factor 1alpha coding mutations are an uncommon contributor to early-onset type 2 diabetes in Ashkenazi Jews. , 1998, Diabetes.

[32]  A. M. Møller,et al.  Genetic variation in the hepatocyte nuclear factor-1a gene in Danish Caucasians with late-onset NIDDM , 1997, Diabetologia.

[33]  R. Turner,et al.  Mutations in the Hepatocyte Nuclear Factor-1α Gene in MODY and Early-Onset NIDDM: Evidence for a Mutational Hotspot in Exon 4 , 1997, Diabetes.

[34]  Sergio Atala Dib,et al.  Prevalência dos marcadores imunológicos Anti-GAD e Anti-IA2 em parentes de primeiro grau de diabéticos do tipo 1 em amostra da população da Grande São Paulo , 2003 .

[35]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[36]  B. Zinman,et al.  The private hepatocyte nuclear factor-1alpha G319S variant is associated with plasma lipoprotein variation in Canadian Oji-Cree. , 2000, Arteriosclerosis, thrombosis, and vascular biology.